Visual Outcomes After Cataract Surgery in Diabetic Eyes

Article

Katherine Talcott, MD, of the Cole Eye Institute, discusses the results of a study she co-authored from AAO 2019 that examined visual acuity outcomes after cataract extraction with IOL implantation with diabetic eyes.

New research from investigators at the Cole Eye Institute is revealing more about the impact of cataract extraction with intraocular lens (IOL) implantation in eyes with and without diabetic retinopathy.

Presented at the American Academy of Ophthalmology (AAO) 2019 Annual Meeting in San Francisco, results of the study revealed eyes with diabetic retinopathy had similar gains to eyes without the condition, but eyes with severe nonproliferative diabetic retinopathy(NPDR) had the most potential for improvement.

In their study of diabetic eyes, all of which underwent cataract extraction at the Cleveland Clinic between 2013 and 2019, improvements in BCVA were noted among all eyes, regardless of disease state(P<0.0001). Of the eyes examined, 138 had no diabetic retinopathy, 102 had mild/moderate NPDR, 24 had severe NPDR, and 73 had proliferative diabetic retinopathy.

Investigators observed mean improvements of 16.4 ± 18.7 letters in eyes without diabetic retinopathy, 16.3 ± 19.1 in eyes with mild/moderate NPDR, 25.3 ± 20.1 in eyes with severe NPDR, and 18.7 ± 21.2 in eyes with proliferative diabetic retinopathy.

For more on the clinical takeaways of the analysis, hear from study co-author Katherine Talcott, MD, of Cole Eye Institute, in the video below.

MD Mag: What were the results of your study examining visual outcomes after cataract extraction in patients with diabetic retinopathy?

Talcott: So, I think it's a little confusing for sort of us as retina specialists to sort of figure out when to refer people for cataract surgery versus not if they have something like diabetic retinopathy because it's hard to sometimes tell if the cataract is affecting their vision or if it's the retina that's affecting their vision.

So, we wanted to sort of better tease out among different severities of diabetic retinopathy sort of how much visual acuity you could potentially get after having cataract surgery. We look sort of retrospectively at those patients to be able to tease that out and we basically found that when you sort of stratify patients by their diabetic retinopathy the patients who had more severe retinopathy had more visual acuity gain than those who had less severe, but if you looked at sort of what final vision they end up with they still end up with not as good final vision as the patients who have less severe retinopathy.

So, I think that means that we're probably referring those patients less to have cataract surgery then you would someone who doesn't have as much retinopathy or those patients are sort of presenting to us later when they have sort of more extensive disease both in terms of retinopathy and in terms of cataract. I think a lot of retina specialist are probably less likely to refer those patients. Those patients still get a lot of benefit from cataract surgery, but we need to sort of temper patient expectations as to what visual acuity they might end up with after cataract surgery.

Recent Videos
Arshad Khanani, MD: Four-Year Outcomes of Faricimab for DME in RHONE-X | Image Credit: Sierra Eye Associates
Dilraj Grewal, MD: Development of MNV in Eyes with Geographic Atrophy in GATHER | Image Credit: Duke Eye Center
Margaret Chang, MD: Two-Year Outcomes of the PDS for Diabetic Retinopathy | Image Credit: Retina Consultants Medical Group
Carl C. Awh, MD: | Image Credit:
Raj K. Maturi, MD: 4D-150 for nAMD in PRISM Population Extension Cohort | Image Credit: Retina Partners Midwest
Charles C. Wykoff, MD, PhD: Interim Analysis on Ixo-Vec Gene Therapy for nAMD | Image Credit: Retina Consultants of Texas
Sunir J. Garg, MD: Pegcetacoplan Preserves Visual Function on Microperimetry | Image Credit: Wills Eye Hospital
Edward H. Wood, MD: Pharmacodynamics of Subretinal RGX-314 for Wet AMD | Image Credit: Austin Retina Associates
Dilsher Dhoot, MD: OTX-TKI for NPDR in Interim Phase 1 HELIOS Results  | Image Credit: LinkedIn
Katherine Talcott, MD: Baseline EZ Integrity Features Predict GA Progression | Image Credit: LinkedIn
© 2024 MJH Life Sciences

All rights reserved.